Open AccessPostoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry
Author(s) -
Piotr Kasina,
Alexander Wall,
Lasse J Lapidus,
Ola Rolfson,
Johan Kärrholm,
Szilárd Nemes,
Bengt I. Eriksson,
Maziar Mohaddes
Publication year - 2019
Publication title -
clinical orthopaedics and related research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.178
H-Index - 204
eISSN - 1528-1132
pISSN - 0009-921X
DOI - 10.1097/corr.0000000000000714
Subject(s) - medicine , pulmonary embolism , surgery , low molecular weight heparin , arthroplasty , thrombosis , deep vein , antithrombotic , odds ratio , rivaroxaban , randomized controlled trial , population , warfarin , atrial fibrillation , environmental health
Although the use of thromboprophylaxis is well established, there is no consensus on the preferred thromboprophylaxis regimen after THA; large, population-based studies offer an opportunity to examine this problem in a robust way that can complement results from randomized trials.